114 related articles for article (PubMed ID: 35394130)
1. mGluR5 promotes the progression of multiple myeloma in vitro via Ras-MAPK signaling pathway.
Kou W; Huang H; Dai S; Tan X; Chen Q; Huang R; Zou H
Adv Clin Exp Med; 2022 Aug; 31(8):881-888. PubMed ID: 35394130
[TBL] [Abstract][Full Text] [Related]
2. Activation of type 5 metabotropic glutamate receptor promotes the proliferation of rat retinal progenitor cell via activation of the PI-3-K and MAPK signaling pathways.
Zhang Z; Hu F; Liu Y; Ma B; Chen X; Zhu K; Shi Y; Wei T; Xing Y; Gao Y; Lu H; Liu Y; Kang Q
Neuroscience; 2016 May; 322():138-51. PubMed ID: 26902516
[TBL] [Abstract][Full Text] [Related]
3. microRNA-195 Promotes Small Cell Lung Cancer Cell Apoptosis via Inhibiting Rap2C Protein-Dependent MAPK Signal Transduction.
Tong J; Lu J; Yin Y; Wang Y; Zhang K
Technol Cancer Res Treat; 2020; 19():1533033820977546. PubMed ID: 33302819
[TBL] [Abstract][Full Text] [Related]
4. USO1 promotes tumor progression via activating Erk pathway in multiple myeloma cells.
Jin Y; Dai Z
Biomed Pharmacother; 2016 Mar; 78():264-271. PubMed ID: 26898451
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21 contributes to high glucose-induced fibrosis in peritoneal mesothelial cells in rat models by activation of the Ras-MAPK signaling pathway via Sprouty-1.
Gao Q; Xu L; Yang Q; Guan TJ
J Cell Physiol; 2019 May; 234(5):5915-5925. PubMed ID: 30515805
[TBL] [Abstract][Full Text] [Related]
6. Metabotropic glutamate receptor 5 mediates the suppressive effect of 6-OHDA-induced model of Parkinson's disease on liver cancer.
Xi SS; Bai XX; Gu L; Bao LH; Yang HM; An W; Wang XM; Zhang H
Pharmacol Res; 2017 Jul; 121():145-157. PubMed ID: 28455267
[TBL] [Abstract][Full Text] [Related]
7. Differential Expression of MicroRNA-19b Promotes Proliferation of Cancer Stem Cells by Regulating the TSC1/mTOR Signaling Pathway in Multiple Myeloma.
Wang N; Liang X; Yu W; Zhou S; Fang M
Cell Physiol Biochem; 2018; 50(5):1804-1814. PubMed ID: 30396185
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of RTN1-C attenuates MPP
Chang J; Zhang XL; Yu H; Chen J
Brain Res Bull; 2019 Mar; 146():1-6. PubMed ID: 30521940
[TBL] [Abstract][Full Text] [Related]
9. Silencing Aurora-kinase-A (AURKA) reinforced the sensitivity of diffuse large B-cell lymphoma cells to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) via suppressing β-Catenin and RAS-extracellular signal-regulated protein kinase (ERK1/2) pathway.
Wang S; Sun L
Bioengineered; 2021 Dec; 12(1):8296-8308. PubMed ID: 34565287
[TBL] [Abstract][Full Text] [Related]
10. Sirtuin 2 knockdown inhibits cell proliferation and RAS/ERK signaling, and promotes cell apoptosis and cell cycle arrest in multiple myeloma.
Ding T; Hao J
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476507
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of Sprouty homolog 2 by microRNA-21 inhibits proliferation, metastasis and invasion, however promotes the apoptosis of multiple myeloma cells.
Wang JH; Zhou WW; Cheng ST; Liu BX; Liu FR; Song JQ
Mol Med Rep; 2015 Aug; 12(2):1810-6. PubMed ID: 25825239
[TBL] [Abstract][Full Text] [Related]
12. The involvement of the mGluR5-mediated JNK signaling pathway in rats with diabetic retinopathy.
Zhu YN; Zuo GJ; Wang Q; Chen XM; Cheng JK; Zhang S
Int Ophthalmol; 2019 Oct; 39(10):2223-2235. PubMed ID: 30607864
[TBL] [Abstract][Full Text] [Related]
13. Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease.
Zhang YN; Fan JK; Gu L; Yang HM; Zhan SQ; Zhang H
J Neuroinflammation; 2021 Jan; 18(1):23. PubMed ID: 33461598
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2 Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase (MAPK)-mediated G2/M Progression Delay and Cell Apoptosis.
Liu Q; Tao B; Liu G; Chen G; Zhu Q; Yu Y; Yu Y; Xiong H
J Biol Chem; 2016 Feb; 291(9):4779-92. PubMed ID: 26724804
[TBL] [Abstract][Full Text] [Related]
15. Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma.
Sriskandarajah P; De Haven Brandon A; MacLeod K; Carragher NO; Kirkin V; Kaiser M; Whittaker SR
BMC Cancer; 2020 Mar; 20(1):269. PubMed ID: 32228485
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA UCA1 regulates proliferation and apoptosis in multiple myeloma by targeting miR-331-3p/IL6R axis for the activation of JAK2/STAT3 pathway.
Li JL; Liu XL; Guo SF; Yang Y; Zhu YL; Li JZ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9238-9250. PubMed ID: 31773675
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5).
Haas LT; Kostylev MA; Strittmatter SM
J Biol Chem; 2014 Oct; 289(41):28460-77. PubMed ID: 25148681
[TBL] [Abstract][Full Text] [Related]
18. Activated mGluR5 protects BV2 cells against OGD/R induced cytotoxicity by modulating BDNF-TrkB pathway.
Ye X; Yu L; Zuo D; Zhang L; Zu J; Hu J; Tang J; Bao L; Cui C; Zhang R; Jin G; Zan K; Zhang Z; Yang X; Shi H; Zhang Z; Xiao Q; Liu Y; Xiang J; Zhang X; Cui G
Neurosci Lett; 2017 Jul; 654():70-79. PubMed ID: 28642149
[TBL] [Abstract][Full Text] [Related]
19. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
[TBL] [Abstract][Full Text] [Related]
20. The role of metabotropic glutamate receptor 5 on the stromal cell-derived factor-1/CXCR4 system in oral cancer.
Kuribayashi N; Uchida D; Kinouchi M; Takamaru N; Tamatani T; Nagai H; Miyamoto Y
PLoS One; 2013; 8(11):e80773. PubMed ID: 24236200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
